Financhill
Sell
27

ECOR Quote, Financials, Valuation and Earnings

Last price:
$8.00
Seasonality move :
1.72%
Day range:
$7.96 - $8.50
52-week range:
$5.32 - $19.49
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.39x
P/B ratio:
7.66x
Volume:
108.3K
Avg. volume:
188.2K
1-year change:
26.06%
Market cap:
$57.8M
Revenue:
$25.2M
EPS (TTM):
-$1.62

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
ECOR
electroCore
$7.1M -- 25.79% -- $25.20
APYX
Apyx Medical
$13.4M -$0.16 -3.15% -40.91% $2.88
ATEC
Alphatec Holdings
$172.7M -$0.07 21.01% -64.45% $18.04
KRMD
KORU Medical Systems
$8.9M -$0.02 8.12% -31.25% $5.70
NURO
NeuroMetrix
-- -- -- -- --
OWLT
Owlet
$17.1M -$0.48 22.98% -58.82% $11.75
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
ECOR
electroCore
$8.03 $25.20 $57.8M -- $0.00 0% 2.39x
APYX
Apyx Medical
$1.16 $2.88 $43.8M -- $0.00 0% 0.86x
ATEC
Alphatec Holdings
$10.20 $18.04 $1.5B -- $0.00 0% 2.38x
KRMD
KORU Medical Systems
$2.95 $5.70 $135.6M -- $0.00 0% 4.02x
NURO
NeuroMetrix
$4.58 -- $9.4M -- $0.00 0% 2.13x
OWLT
Owlet
$4.15 $11.75 $68.8M -- $0.00 0% 0.59x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
ECOR
electroCore
-- -2.016 -- 1.46x
APYX
Apyx Medical
70.46% 0.879 56.64% 4.40x
ATEC
Alphatec Holdings
102.52% 0.619 43.55% 1.45x
KRMD
KORU Medical Systems
1.59% 3.558 0.15% 2.16x
NURO
NeuroMetrix
-- 0.088 -- 12.38x
OWLT
Owlet
-228.59% -1.218 14.88% 0.89x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
ECOR
electroCore
$6.1M -$3.1M -147.07% -147.07% -43.59% -$1.3M
APYX
Apyx Medical
$9M -$3M -45.86% -133.56% -20.51% -$3.2M
ATEC
Alphatec Holdings
$121.6M -$20.9M -29.29% -691.37% -14.56% $6.8M
KRMD
KORU Medical Systems
$5.6M -$1.6M -32.31% -32.71% -17.98% $981.9K
NURO
NeuroMetrix
$312K -$1.7M -41.7% -41.7% -296.61% -$1.8M
OWLT
Owlet
$11M -$7.4M -- -- -37.31% $3.3M

electroCore vs. Competitors

  • Which has Higher Returns ECOR or APYX?

    Apyx Medical has a net margin of -45.81% compared to electroCore's net margin of -32.54%. electroCore's return on equity of -147.07% beat Apyx Medical's return on equity of -133.56%.

    Company Gross Margin Earnings Per Share Invested Capital
    ECOR
    electroCore
    85.89% -$0.40 $7.5M
    APYX
    Apyx Medical
    63.03% -$0.12 $48.2M
  • What do Analysts Say About ECOR or APYX?

    electroCore has a consensus price target of $25.20, signalling upside risk potential of 213.82%. On the other hand Apyx Medical has an analysts' consensus of $2.88 which suggests that it could grow by 244.83%. Given that Apyx Medical has higher upside potential than electroCore, analysts believe Apyx Medical is more attractive than electroCore.

    Company Buy Ratings Hold Ratings Sell Ratings
    ECOR
    electroCore
    3 0 0
    APYX
    Apyx Medical
    1 3 0
  • Is ECOR or APYX More Risky?

    electroCore has a beta of 0.244, which suggesting that the stock is 75.612% less volatile than S&P 500. In comparison Apyx Medical has a beta of 1.184, suggesting its more volatile than the S&P 500 by 18.437%.

  • Which is a Better Dividend Stock ECOR or APYX?

    electroCore has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Apyx Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. electroCore pays -- of its earnings as a dividend. Apyx Medical pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ECOR or APYX?

    electroCore quarterly revenues are $7M, which are smaller than Apyx Medical quarterly revenues of $14.2M. electroCore's net income of -$3.2M is higher than Apyx Medical's net income of -$4.6M. Notably, electroCore's price-to-earnings ratio is -- while Apyx Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for electroCore is 2.39x versus 0.86x for Apyx Medical. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ECOR
    electroCore
    2.39x -- $7M -$3.2M
    APYX
    Apyx Medical
    0.86x -- $14.2M -$4.6M
  • Which has Higher Returns ECOR or ATEC?

    Alphatec Holdings has a net margin of -45.81% compared to electroCore's net margin of -18.85%. electroCore's return on equity of -147.07% beat Alphatec Holdings's return on equity of -691.37%.

    Company Gross Margin Earnings Per Share Invested Capital
    ECOR
    electroCore
    85.89% -$0.40 $7.5M
    ATEC
    Alphatec Holdings
    68.77% -$0.23 $562M
  • What do Analysts Say About ECOR or ATEC?

    electroCore has a consensus price target of $25.20, signalling upside risk potential of 213.82%. On the other hand Alphatec Holdings has an analysts' consensus of $18.04 which suggests that it could grow by 76.88%. Given that electroCore has higher upside potential than Alphatec Holdings, analysts believe electroCore is more attractive than Alphatec Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    ECOR
    electroCore
    3 0 0
    ATEC
    Alphatec Holdings
    6 1 0
  • Is ECOR or ATEC More Risky?

    electroCore has a beta of 0.244, which suggesting that the stock is 75.612% less volatile than S&P 500. In comparison Alphatec Holdings has a beta of 1.388, suggesting its more volatile than the S&P 500 by 38.793%.

  • Which is a Better Dividend Stock ECOR or ATEC?

    electroCore has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alphatec Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. electroCore pays -- of its earnings as a dividend. Alphatec Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ECOR or ATEC?

    electroCore quarterly revenues are $7M, which are smaller than Alphatec Holdings quarterly revenues of $176.8M. electroCore's net income of -$3.2M is higher than Alphatec Holdings's net income of -$33.3M. Notably, electroCore's price-to-earnings ratio is -- while Alphatec Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for electroCore is 2.39x versus 2.38x for Alphatec Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ECOR
    electroCore
    2.39x -- $7M -$3.2M
    ATEC
    Alphatec Holdings
    2.38x -- $176.8M -$33.3M
  • Which has Higher Returns ECOR or KRMD?

    KORU Medical Systems has a net margin of -45.81% compared to electroCore's net margin of -17.66%. electroCore's return on equity of -147.07% beat KORU Medical Systems's return on equity of -32.71%.

    Company Gross Margin Earnings Per Share Invested Capital
    ECOR
    electroCore
    85.89% -$0.40 $7.5M
    KRMD
    KORU Medical Systems
    62.94% -$0.03 $17.1M
  • What do Analysts Say About ECOR or KRMD?

    electroCore has a consensus price target of $25.20, signalling upside risk potential of 213.82%. On the other hand KORU Medical Systems has an analysts' consensus of $5.70 which suggests that it could grow by 93.22%. Given that electroCore has higher upside potential than KORU Medical Systems, analysts believe electroCore is more attractive than KORU Medical Systems.

    Company Buy Ratings Hold Ratings Sell Ratings
    ECOR
    electroCore
    3 0 0
    KRMD
    KORU Medical Systems
    4 1 0
  • Is ECOR or KRMD More Risky?

    electroCore has a beta of 0.244, which suggesting that the stock is 75.612% less volatile than S&P 500. In comparison KORU Medical Systems has a beta of 0.735, suggesting its less volatile than the S&P 500 by 26.468%.

  • Which is a Better Dividend Stock ECOR or KRMD?

    electroCore has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. KORU Medical Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. electroCore pays -- of its earnings as a dividend. KORU Medical Systems pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ECOR or KRMD?

    electroCore quarterly revenues are $7M, which are smaller than KORU Medical Systems quarterly revenues of $8.8M. electroCore's net income of -$3.2M is lower than KORU Medical Systems's net income of -$1.6M. Notably, electroCore's price-to-earnings ratio is -- while KORU Medical Systems's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for electroCore is 2.39x versus 4.02x for KORU Medical Systems. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ECOR
    electroCore
    2.39x -- $7M -$3.2M
    KRMD
    KORU Medical Systems
    4.02x -- $8.8M -$1.6M
  • Which has Higher Returns ECOR or NURO?

    NeuroMetrix has a net margin of -45.81% compared to electroCore's net margin of -256.8%. electroCore's return on equity of -147.07% beat NeuroMetrix's return on equity of -41.7%.

    Company Gross Margin Earnings Per Share Invested Capital
    ECOR
    electroCore
    85.89% -$0.40 $7.5M
    NURO
    NeuroMetrix
    53.12% -$0.75 $16M
  • What do Analysts Say About ECOR or NURO?

    electroCore has a consensus price target of $25.20, signalling upside risk potential of 213.82%. On the other hand NeuroMetrix has an analysts' consensus of -- which suggests that it could grow by 8625.05%. Given that NeuroMetrix has higher upside potential than electroCore, analysts believe NeuroMetrix is more attractive than electroCore.

    Company Buy Ratings Hold Ratings Sell Ratings
    ECOR
    electroCore
    3 0 0
    NURO
    NeuroMetrix
    0 0 0
  • Is ECOR or NURO More Risky?

    electroCore has a beta of 0.244, which suggesting that the stock is 75.612% less volatile than S&P 500. In comparison NeuroMetrix has a beta of 2.153, suggesting its more volatile than the S&P 500 by 115.333%.

  • Which is a Better Dividend Stock ECOR or NURO?

    electroCore has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroMetrix offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. electroCore pays -- of its earnings as a dividend. NeuroMetrix pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ECOR or NURO?

    electroCore quarterly revenues are $7M, which are larger than NeuroMetrix quarterly revenues of $587.3K. electroCore's net income of -$3.2M is lower than NeuroMetrix's net income of -$1.5M. Notably, electroCore's price-to-earnings ratio is -- while NeuroMetrix's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for electroCore is 2.39x versus 2.13x for NeuroMetrix. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ECOR
    electroCore
    2.39x -- $7M -$3.2M
    NURO
    NeuroMetrix
    2.13x -- $587.3K -$1.5M
  • Which has Higher Returns ECOR or OWLT?

    Owlet has a net margin of -45.81% compared to electroCore's net margin of -44.19%. electroCore's return on equity of -147.07% beat Owlet's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    ECOR
    electroCore
    85.89% -$0.40 $7.5M
    OWLT
    Owlet
    53.52% -$0.63 -$5.1M
  • What do Analysts Say About ECOR or OWLT?

    electroCore has a consensus price target of $25.20, signalling upside risk potential of 213.82%. On the other hand Owlet has an analysts' consensus of $11.75 which suggests that it could grow by 183.13%. Given that electroCore has higher upside potential than Owlet, analysts believe electroCore is more attractive than Owlet.

    Company Buy Ratings Hold Ratings Sell Ratings
    ECOR
    electroCore
    3 0 0
    OWLT
    Owlet
    2 0 0
  • Is ECOR or OWLT More Risky?

    electroCore has a beta of 0.244, which suggesting that the stock is 75.612% less volatile than S&P 500. In comparison Owlet has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock ECOR or OWLT?

    electroCore has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Owlet offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. electroCore pays -- of its earnings as a dividend. Owlet pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ECOR or OWLT?

    electroCore quarterly revenues are $7M, which are smaller than Owlet quarterly revenues of $20.5M. electroCore's net income of -$3.2M is higher than Owlet's net income of -$9.1M. Notably, electroCore's price-to-earnings ratio is -- while Owlet's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for electroCore is 2.39x versus 0.59x for Owlet. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ECOR
    electroCore
    2.39x -- $7M -$3.2M
    OWLT
    Owlet
    0.59x -- $20.5M -$9.1M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Roblox Stock a Buy, Sell or Hold?
Is Roblox Stock a Buy, Sell or Hold?

Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…

Is Shopify a Millionaire Maker?
Is Shopify a Millionaire Maker?

Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
95
EXOD alert for Mar 21

Exodus Movement [EXOD] is up 17.89% over the past day.

Buy
58
SIG alert for Mar 21

Signet Jewelers [SIG] is down 0.64% over the past day.

Sell
43
HQY alert for Mar 21

HealthEquity [HQY] is up 0.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock